SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178031-16-000002
Filing Date
2016-12-13
Accepted
2016-12-13 12:07:11
Documents
2
Period of Report
2016-12-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3784
2 POWER OF ATTORNEY poa-snyderman.txt EX-24 4462
  Complete submission text file 0001178031-16-000002.txt   9673
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAIC 10260 CAMPUS POINT DR M/S F3 SAN DIEGO CA 92121
Business Address
SNYDERMAN RALPH (Reporting) CIK: 0001178031 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 162048015